The Convergent Science Cancer Consortium, a consortium using an unconventional approach that emphasizes the integration of diverse scientific disciplines, received a $3.2 million grant from the U.S. Department of Defense.
Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the disease.
